Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Composition of scalable thyrointegrin antagonists with improved retention in tumors

Composition of scalable thyrointegrin antagonists with improved retention in tumors

US Patent 11186551 · Granted Nov 30, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulated and/or co-formulated liposome compositions containing toll-like recep2025
Formulated and/or co-formulated liposome compositions containing IDO antagonist 2025
Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) nano-formulation2025
Method for treatment of a viral-mediated infectious disease2025
Population control using engineered translocations2025
DNA sequence modification-based gene drive2024
Formulated and/or co-formulated liposome compositions containing PD-1 antagonist2024
DNA sequence modification-based gene drive2024
Formulated and/or co-formulated liposome compositions containing toll-like recep2024
Formulated and/or co-formulated liposome compositions containing PD-1 antagonist2023
Formulated and/or co-formulated liposome compositions containing TFGB antagonist2023
Formulated and/or co-formulated liposome compositions containing toll-like recep2023